OBRIEN JAMES J /KY 4

What Happened James J. O'Brien, a director of Eastman Chemical Company (EMN), was credited with 408 phantom stock units on 2026-04-08. The Form 4 reports the transaction as an award/grant (code A) at $0.00 per unit — this reflects a grant of derivative phantom units rather than a cash purchase of shares. These units have a value equal to one share of EMN and are payable in cash after termination of director service.

Key Details

• Transaction date: 2026-04-08; filing date: 2026-04-10 (timely filing).
• Transaction type/code: Award/grant (A) of 408 phantom stock units; reported price $0.00 (derivative units).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 — units are phantom stock payable only in cash after termination; F2 — units include amounts from an automatic deferral of director retainer fees; F3 — includes reinvested dividend equivalents.
• Not an open‑market purchase or sale; this is director compensation (cash‑settled derivative units), not an equity purchase.

Context Phantom stock units track the market value of the company's shares but do not represent actual share ownership, voting rights, or immediate stock purchases. They are typically used as deferred, cash‑settled director compensation and should be viewed as routine remuneration rather than a direct buy/sell signal.